Log in

Ipsen: European green light to commercialize treatment for tumor-related diarrhea

The French pharmaceutical group Ipsen announced Tuesday that it has received authorization from the European Commission to commercialize Xermelo Union, a treatment for symptomatic diarrhea of ​​certain neuroendocrine tumors.


The French manufacturer of generics Biogaran put on the international and biosimilars

The French manufacturer of generics Biogaran, a subsidiary of the Servier group, expects to double its turnover in ten years, notably by increasing sales abroad and its launches of biosimilar drugs, said Tuesday its president.


Scientific analyzes: Eurofins buys American EAG for 780 M USD

Eurofins, a specialist in biopharmaceutical, food and environmental analysis services, announced Monday the acquisition of 780 million US dollars from EAG, putting a foot in the US with the acquisition of a group active in sectors.


Biogaran could revive its generic Levothyrox at the end of the year

Biogaran, a subsidiary of the pharmaceutical group Servier, will be able to bring its old generic Levothyrox to market by "2 month, 2 month and a half", subject to the green light from the drug agency, of the laboratory.


Ipsen: new indication for its flagship product in the United States

The French pharmaceutical group Ipsen announced Monday that the US Agency for Drugs (FDA) had authorized a new oncology indication of its flagship product Somatuline, which makes the bulk of its sales in the United States.


a3p-100pxhaut logo


Commit to share
Transmit and progress together
Promoting innovation

The A3P Association is a major player in the pharmaceutical and biotechnology industry.
Created in 1986, it contributes to the good development of the production of medicines and clean and sterile equipment, it runs a network of professionals 21 000, manufacturers and suppliers, as part of International Congress and technical days.

It now has over 1700 members who share their technical experience, scientific and regulatory.

More info on video (Versiongb here )

  group    administrators A3P
& Project Managers

letter   newsletter A3P